Acadia Golden Retrievers, Education, Litter Research

03/04/2025

https://www.cuteness.com/1784872/ticks-hide-in-dogs-paws-what-to-know/

Dogs that have been outside are susceptible to ticks. Here are the top spots to check your pup for ticks when coming indoors - and how to remove them.

02/20/2025

Happy Birthday!

02/12/2025

A very HAPPY 10th BIRTHDAY to my sweet girl, Fatalii, on this cold, rainy day - much like when she was born! 🎂💖❌⭕❌

01/26/2025

1/24/25

01/24/2025

HAPPY 7th BIRTHDAY, Jamie, my sweet boy! ❌⭕❌ 🎂 💖

01/01/2025

12/25/2024

Merry Christmas!

11/19/2024

https://www.petpoisonhelpline.com/pet-owners/

We offer extensive guides on pet safety. From the basics to pet loss support, Pet Poison Helpline® is a beneficial resource for pet owners and vets.

11/10/2024

11/9/24 - Celebrating #8 with family today! 🎂💖

11/10/2024

11/9/24 - HAPPY 8th BIRTHDAY to my beautiful Sami! ❌⭕❌ ❤️

10/11/2024

FYI:

10/09/2024

FYI: A new vaccine trial for canines with early stage hemangiosarcoma (HSA) is underway. Calviri, a biotechnology company that creates therapeutic and preventative cancer vaccines for dogs and humans, announced it has vaccinated its first participant with its investigational immunotherapy vaccine.

The study, titled the Scout Out Canine Hemangiosarcoma (SOCH), aims to explore whether Calviri's “pre-made” vaccine can lengthen the lifespan of dogs with stage 1 or stage 2 tumors when paired with standard care treatment like surgery and chemotherapy. The vaccine’s objective is to activate the immune system to identify and destroy cancer cells.

The new vaccine differentiates itself from other cancer vaccines, which are generally used to treat advanced-stage tumors in humans and dogs. The SOCH trial is set to be the first to target early-stage tumors, aiming to improve survival rates by treating these smaller, less advanced tumors.

"HSA is very aggressive. If this vaccine approach proves effective for HSA, there is a good chance it will work for other tumors," Douglas Thamm, VMD, director of clinical research at Colorado State University's (CSU) Flint Animal Cancer Center, and lead of the trial at CSU, said in a news release.

In dogs, HSA is prevalent, particularly among golden retrievers, German shepherds, labrador retrievers, boxers, pit bulls, and dogs with thin hair coats like Greyhounds, beagles, and dalmatians.

HSA usually begins in the spleen and has the potential to metastasize (spread) to other areas.

HSA tumors consist of abnormal blood cells and fragile blood vessels that are invasive and prone to rupture. When these tumors rupture, they bleed into body cavities such as the chest or abdomen, leading to many of the clinical symptoms linked to this disease.

Although HSA is generally diagnosed at more advanced stages, even early detection typically results in a life expectancy of 5 to 11 months.

Typical treatment includes surgical removal of the cancerous spleen and chemotherapy.

Additional treatment consists of anti-bleeding medications, bioactive extracts from mushrooms, anti-arrhythmic drugs, blood transfusions, and procedures to remove fluid from around the heart or in the chest or abdomen.

"HSA is a devastating diagnosis for dogs. We are hopeful that this unique vaccine will improve the prognosis,” David Vail, DVM, MS, DACVIM (oncology), and clinical principal investigator for the study, said in the release.

Dogs will be enrolled in the study at the academic veterinary oncology institutions at the University of Wisconsin, Colorado State University, and the University of California-Davis. Participants will be randomly assigned to either a group receiving a placebo vaccine or one receiving the investigational vaccine. Both groups will also receive standard treatment, which consists of surgery and chemotherapy, along with their assigned vaccine. The study is expected to continue for two years, with a goal of enrolling up to 80 dogs.

Participants will be randomly placed into either a control group that receives a placebo vaccine or a test group that receives the investigational vaccine. All dogs, regardless of group, will receive standard care, comprising of surgery and chemotherapy, along with the mock or investigational vaccine. The study is anticipated to run for 2 years and will enroll up to 80 dogs, according to the release.

Sami Al-Nadaf, DVM, trial director at UC-Davis Veterinary Medicine, invited veterinarians and dog owners who are interested to email [email protected] for further details.

“The faster we can enroll dogs, the sooner we will find out if the vaccine can help those diagnosed with HSA," he said in the release.

Funding for the trial comes from Calviri and a donation from David MacNeil in remembrance of his golden retriever Scout, famous for featuring in multiple Super Bowl commercials.

Send a message to learn more

10/09/2024

Solace, a Patchouli daughter, bringing comfort, in Asheville, NC

10/05/2024

Acadia Some Like It Scot
Majik Just A Gi**lo, CGC, TKN - Julian x Blackpool Acadia Gaga Oh La La - Romah
DOB: 10/5/18 HAPPY BIRTHDAY! ❤️🎂

09/09/2024

NatBA CH Acadia Rock U Like A Hurricane "Devin"
Acadia Amore Eterno - "Braedon" x Acadia's Bewitchery - "Nicolett"
DOB: 9/9/19 HAPPY BIRTHDAY! 🎂❤️

08/10/2024

13 years ago today - Tomi and Patchouli (1/2 sisters) with their eight 4 1/2 week old babies sired by Sisko - that's Scarlett in the front! Wonderful memories of these two special girls raising their puppies together!

07/28/2024

A VERY HAPPY 1st BIRTHDAY, TAIKA - Acadia So Ya Wanna Play W'Magic! ❤️
Am Ch Honor's Kindle Wanna Drive 'Em Wild "Justin" x NatSR/IntSR J'Suis Toujours Obsedee Of Nova Mist CCA "Janessa"